NAMs are reshaping biomedical research by offering more human-relevant approaches to studying disease and treatment response. Prof. Igor Balaž discusses how organoids, organ-on-chip systems, advanced data analysis, and digital twins can work together to improve preclinical research and drug development.

CancerScan brings together organoids, AI and tumour digital twins to advance precision oncology. In this podcast, Irena Milobratović and Prof. Igor Balaž discuss the project’s approach to predicting patient-specific treatment response and translating innovative research towards clinical practice.

Irena Milobratović speaks with Igor Balaž about BioMeld’s approach to biohybrid machine design and the role of AI, simulations, and human expertise in advancing this emerging technology.